Search research articles

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Blood Transfusion

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Access to Assisted Reproductive Technologies in Australia: Time for Legislative Change in Queensland and the Northern Territory to Remove the Ability to Discriminate Based on Relationship Status or Sexuality.

Journal of law and medicine·2023

Same author

The motivations of donor-conceived adults for seeking information about, and contact with, sperm donors.

Reproductive biomedicine online·2021

Same author

The Regulation and Governance of Clinical Trials: Past and Present Considerations to Ensure Ethical Treatment of Human Participants.

Journal of law and medicine·2021

Same author

Absence of laws regarding sperm and oocyte donation in Japan and the impacts on donors, parents, and the people born as a result.

Reproductive medicine and biology·2020

Same author

A governance model for the application of AI in health care.

Journal of the American Medical Informatics Association : JAMIA·2019

Same author

The Impact of the Law in Helping or Hindering Fertility Preservation for Children with Cancer Facing Gonadotoxic Therapies.

Journal of law and medicine·2018

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 18, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Donor identification 'kills gamete donation'? A response.

¹Deakin University, Victoria, Australia. sonia.allan@deakin.edu.au

Human Reproduction (Oxford, England)

|October 5, 2012

Summary

Donor-conceived individuals seek information about their gamete donors, prompting government inquiries for legislative reform. This paper advocates for openness and compromise, addressing concerns about donor anonymity and donation rates.

Area of Science:

Reproductive Law and Ethics
Assisted Reproductive Technology
Family Law and Donor Conception

Background:

Recent Australian government inquiries recommend releasing donor information to donor-conceived individuals.
These inquiries propose national uniform legislation and retrospective laws overriding donor anonymity.
Professor Pennings criticized these recommendations, questioning advocates' motives and the impact on gamete donation.

Purpose of the Study:

To respond to criticisms regarding information release for donor-conceived individuals.
To advocate for considering all parties affected by donor conception and reaching a compromise.
To address concerns about donor anonymity, potential decreases in gamete donation, and alleged hidden agendas.

Main Methods:

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Published on: March 7, 2013

Related Experiment Videos

Last Updated: May 18, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Published on: March 7, 2013

Critical analysis and rebuttal of arguments presented by Professor Pennings.

Discussion of proposed compromises, such as the contact veto system.

Examination of recommended support services and legislative implications.

Main Results:

Argues for a balanced approach considering the rights and needs of donor-conceived individuals, donors, and recipients.
Contends that the contact veto system offers a viable compromise.
Rebuts claims that information release will deter gamete donation and refutes the existence of a 'hidden agenda'.

Conclusions:

Emphasizes the importance of openness and honesty in donor conception.
Advocates for legislative and policy changes that prioritize the well-being of all parties involved.
Calls for addressing discriminatory views rather than impeding the movement towards transparency.